Synthesis, antidepressant evaluation and QSAR studies of novel 2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylthio)-N-(substituted phenyl)acetamides

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 15, 2010, Pages 4661-4664

  Shelke, Suhas M ^a   Bhosale, Sharad H ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

5H 1,2,4 triazino 5,6 b indole; Antidepressant; QSAR; Tail suspension test

Indexed keywords

2 (5H [1,2,4]TRIAZINO[5,6 B]INDOL 3 YLTHIO) N (SUBSTITUTED PHENYL)ACETAMIDE; ACETAMIDE DERIVATIVE; ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; MOCLOBEMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; MALE; MOUSE; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ACETAMIDES; ANIMALS; ANTIDEPRESSIVE AGENTS; LINEAR MODELS; MICE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

MUS;

EID: 77955432319     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.05.100     Document Type: Article

References (29)

1. P. Schloss, and F.A. Henn Pharmacol. Ther. 102 2004 47
2. T.B. Ustun, J.L. Ayuso-Mateos, S. Chatterji, C. Mathers, and C.J. Murray Br. J. Psychiatry 184 2004 386
3. A. Orjales, R. Mosquera, A. Toledo, M.C. Pumar, N. Garcia, L. Cortizo, L. Labeaga, and A. Innerarity J. Med. Chem. 46 2003 5512
4. P.V. Tran, F.P. Bymaster, R.K. McNamara, and W.Z. Potter J. Clin. Psychopharmacol. 23 2003 78
5. F.P. Bymaster, R.K. McNamara, and P.V. Tran Expert Opin. Invest. Drugs 12 2003 531
6. A.B. Tomchin, V.S. Velezheva, and E.B. Shusto Pharm. Chem. J. 32 1998 59
7. M.Z. Jan, R.H. Gladych, J.H. Hunt, and D. Jack J. Med. Chem. 15 1972 277
8. A.B. Tomchin, O.Y. Uryupov, and A.V. Smirnov Pharm. Chem. J. 31 1997 632
9. J.L. Kgokong, P.P. Smith, and G.M. Matsabisa Bioorg. Med. Chem. 13 2005 2935
10. B. Shivarama Holla, and K. Venkatramana Udupa Heterocycles 32 1991 1081
11. H.E. Vabil, H.M. Salama, and M.L. Ibrahim Pharmazie 42 1987 664
12. A.B. Tomchin, S.V. Okovityi, V.S. Velezheva, and A.V. Smirnov Pharm. Chem. J. 32 1998 362
13. K. Hoon, O.S. Sergey, and R.R. Rona Arch. Biochem. Biophys. 337 1997 137
14. M.J. Millan, P. Svenningsson, C.R. Ashby, M. Hill, M. Egeland, A. Dekeyne, M. Brocco, B. Cara, F. Lejeune, N. Thomasson, C. Munoz, E. Mocaer, A. Crossman, L. Cistarelli, S. Girardon, L. Iob, S. Veiga, and A. Gobert J. Pharmacol. Exp. Ther. 324 2008 600
15. Z. Soyer, F.S. Kilic, K. Erol, and V. Pabuccuoglu Arch. Pharm. 337 2004 105
16. Andersson, C.; Schlienger, N.; Fejzic, A.; Hansen, E. L.; Pawlas, J. U.S. Patent 7,476,682, 2009.
17. Y. Huang, P.S. Hammond, B.R. Whirrett, R.J. Kuhner, L. Wu, S.R. Childers, and R.H. Mach J. Med. Chem. 41 1998 2361
18. Z. Soyer, F.M. Kili, K. Erol, and V. Pabucuog Il Farmaco 59 2003 595
19. 5OS Calcd. (Found): C, 61.87 (62.09); H, 4.33 (4.17); N, 20.04 (20.33), S, 9.18 (9.02).
20. L. Stéru, R. Chermat, B. Thierry, and P. Simon Psychopharmacology 85 1985 367
21. P. Zajdel, G. Subra, A.J. Bojarski, B. Duszynska, E. Tatarczynska, A. Nikiforuk, E. Chojnacka-Wojcik, M. Pawlowskib, and J. Martineza Bioorg. Med. Chem. 15 2007 2907
22. Maestro, version 9.0, Schrödinger, LLC, New York, NY, 2009.
23. LigPrep, version 2.3, Schrödinger, LLC, New York, NY, 2009.
24. MacroModel, version 9.7, Schrödinger, LLC, New York, NY, 2009.
25. W.L. Jorgensen, and J. Tirado-Rives J. Am. Chem. Soc. 110 1988 1657
26. G. Kaminski, and W.L. Jorgensen J. Phys. Chem. 100 1996 18010
27. M.L. Lamb, J. Tirado-Rives, and W.L. Jorgensen Bioorg. Med. Chem. 7 1999 851
28. Qikprop, version 3.2, Schrödinger, LLC, New York, NY, 2009.
29. Strike, version 1.8, Schrödinger, LLC, New York, NY, 2009.